Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis
Author(s) -
Seth A. Sharp,
Stephen S. Rich,
Andrew R. Wood,
Samuel E. Jones,
Robin N. Beaumont,
James Harrison,
Darius Schneider,
Jonathan M. Locke,
Jessica Tyrrell,
Michael N. Weedon,
William Hagopian,
Richard A. Oram
Publication year - 2019
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc18-1785
Subject(s) - medicine , standardization , diabetes mellitus , type 2 diabetes , type 1 diabetes , risk assessment , pediatrics , endocrinology , computer security , political science , computer science , law
Previously generated genetic risk scores (GRSs) for type 1 diabetes (T1D) have not captured all known information at non-HLA loci or, particularly, at HLA risk loci. We aimed to more completely incorporate HLA alleles, their interactions, and recently discovered non-HLA loci into an improved T1D GRS (termed the "T1D GRS2") to better discriminate diabetes subtypes and to predict T1D in newborn screening studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom